Johnson and Johnson Single-Dose Vaccine Authorized for Emergency Use Thanks to the Results of the ENSEMBLE Study
Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the U.S. Food and Drug Administration (FDA) has issued Emergency […]
Johnson and Johnson Single Shot COVID-19 Vaccine Unanimously Recommended for EUA by FDA Advisory Committee
A while ago TrialSite predicted that the other vaccine makers in the lead had to keep an eye out for […]
NBA Legend Michael Jordan Gives $10m to Enable Integrated, Whole-Person Patient Care in At Risk Rural Communities
The NBA Basketball GOAT (Greatest of All Time) Michael Jordan, a North Carolina native and resident, recently donated $10 million […]
Black, & Latinos, Native & Elderly Underrepresented in Decade of Vaccine Trials
Scientific Experts from both the U.S. and Puerto Rico recently completed a new stud revealing the great need for diversity […]
Trial Site Roll-up Continues with Headlands Research Buying into CNS Focused SoCal Research Organization—Access to Large & Diverse Population
Trial site organizational merger and acquisition activity continues as Headlands Research recently purchased Artemis Institute for Clinical Research, representing a move […]
Whites Receive COVID-19 Vaccines at 2X to 3X the Rate of Blacks
Whites are signing up for COVID-19 vaccinations at far higher rates than Black Americans, which isn’t a surprise, particularly given […]
Rhode Island’s Lifespan Participates in Phase 3 Clinical Trial Evaluating Novavax COVID-19 Vaccine Candidate
Affiliated with Brown University, Rhode Island Hospitals and Health Services also known as Lifespan now seeks to enroll volunteers for […]
Incoming President-elect to Mobilize FEMA & National Guard to Build COVID-19 Vaccination Clinics
The U.S. war on COVID-19 will become more nationalized with the incoming President-elect Joe Biden as now reports are that […]
After Rushed Development, Close to Half of Healthcare Workers Refusing COVID-19 Vaccines
As reported January 2 by Forbes, many health care and other frontline workers are declining their initial opportunity to receive […]
Eli Lilly’s Monoclonal Antibody Takes a Hit: Bamlanivimab Fails Part of ACTIV-3 Trial: Greater Challenges Ahead?
As TrialSite has reported, Lilly’s Bamlanivimab (or LY-CoV555), despite its hi-tech nature as a monoclonal antibody therapy for COVID-19 with […]
